GlassScriptPhysician profile
Roy William Prescott
NPI 1487477279
$775.69
in general payments reported to CMS, 2019-2025
14 companies · $776 in 2025
The $776 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $671 · Consulting Fee: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $670.69 |
| Consulting Fee | $105.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $297.41 | 2025 | |
| Eisai INC. | $105.00 | 2025 | |
| Novo Nordisk INC | $63.07 | 2025 | Wegovy, Ozempic, Rybelsus |
| Otsuka America Pharmaceutical, INC. | $50.96 | 2025 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $49.88 | 2025 | Breztri |
| Sumitomo Pharma America, INC. | $42.38 | 2025 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $30.05 | 2025 | |
| Lilly USA, LLC | $28.45 | 2025 | Mounjaro |
| Astellas Pharma US INC | $27.63 | 2025 | Veozah |
| Biomarin Pharmaceutical INC. | $21.52 | 2025 | Voxzogo 1.2mg |
| Exact Sciences Corporation | $15.73 | 2025 | Cologuard Collection Kit |
| Amneal Pharmaceuticals LLC | $14.75 | 2025 | Unithroid |
| Axsome Therapeutics, INC. | $14.74 | 2025 | Auvelity |
| Actelion Pharmaceuticals US, INC. | $14.12 | 2025 | Uptravi, Opsumit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Prescott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.